In this file
Comparing alternatives to WeightCare is easier when you first identify what needs to change. WeightCare’s payment menu includes longer packages and financing. An alternative that requires a smaller first payment may still create a longer obligation, so compare the contract as well as the installment size.
The provider’s current comparison point is: Financing a prepaid package does not make it an ordinary monthly subscription. The entries below offer different care and payment arrangements to examine against that point.
How to use this shortlist
CoreAge Rx is listed first under a commercial partnership. The first position is predetermined by that relationship, and links may earn compensation. It is not an independent finding that CoreAge has the safest medicine, the lowest total price, or the strongest patient outcomes.
Use WeightCare’s documented arrangement as the baseline, then test the alternatives against monthly flexibility or a prepaid obligation. We compare public care descriptions and payment terms. We have not purchased treatment, audited every professional license, or timed the support response. Use the linked source notes and obtain a current personal quote.
01. CoreAge Rx · sponsored first position
This is the paid featured reference for the question in this guide. Its placement does not establish that every feature discussed here is available through its program. Ask about the exact product and care access before assuming a match.
CoreAge Rx provides an online route to medical assessment and, where a clinician prescribes, pharmacy fulfillment. The service is our paid featured partner. That commercial relationship buys its prominent position here; it does not establish a better medicine, a better outcome, or suitability for any particular reader.
The sale offer shows starting equivalents of $99 for semaglutide and $149 for tirzepatide, without a separate membership charge. Its billing explanation uses a three-month example: $149 per month becomes a single $447 payment. A reader should obtain the duration and total for the selected prescription rather than assuming that the smaller figure is charged monthly.
A question to put to the provider: Can you send the full payment schedule and the name of my dispensing pharmacy before I accept the offer?
Read the CoreAge Rx provider file and cost explanation for the connected details.
02. Brightmeds
The comparison point for Brightmeds: A seasonal three-month promotion differs from the single-month plan.
Brightmeds’ campaign describes provider visits, medication, and delivery within the offer, without a membership fee. Its monthly arrangement is described as automatically renewing.
The Summer Special page lists semaglutide at $297 for three months or $129 for one month; tirzepatide is $357 for three months or $149 for one. The $99 and $119 monthly equivalents belong to the prepaid campaign.
A question to put to the provider: Is the campaign still eligible for my prescription, and at what rate will the plan renew?
The Brightmeds alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
03. Yucca Health
The comparison point for Yucca Health: The published monthly option costs differently from a six-month prepayment.
Yucca describes a remote assessment and pharmacy-prepared medication when prescribed, without an additional monthly membership. The patient still needs a treatment-specific explanation of follow-up and the pharmacy arrangement.
Semaglutide is displayed at $146 for a monthly plan or $750 paid for six months, equivalent to $125 monthly. Tirzepatide is $258 monthly or $1,350 for six months, equivalent to $225. The lower equivalents require the longer payment commitment.
A question to put to the provider: Is the flexibility of monthly billing worth the difference from the full six-month payment for my situation?
The Yucca Health alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
04. GobyMeds
The comparison point for GobyMeds: A clearly stated starter-bundle total still leaves a renewal question.
GobyMeds describes consultation, injection supplies, and shipping within starter packages. It says there is no separate membership and that the service does not bill insurance.
The listed three-month starter bundles total $299 for semaglutide and $399 for tirzepatide. The corresponding $99 and $133 headlines are rounded monthly equivalents. The first refill may have different eligibility or pricing.
A question to put to the provider: When does the order become non-changeable at the pharmacy, and what is the later package price?
Use the official GobyMeds page to request the current plan and conditions.
05. Fifty 410
The comparison point for Fifty 410: Different package tiers mean a starter total is not the whole price story.
Fifty 410 describes online provider assessment and portal-based follow-up. The pricing material separates semaglutide purchased monthly from three-month tirzepatide packages and includes clinical review, medicine, and shipment in the listed packages.
The tirzepatide starter total is $399 for three months, with other listed tiers at $499 and $549. A monthly semaglutide option is $199. Match the quoted tier and treatment duration to the prescription before comparing those amounts.
A question to put to the provider: Does this package suit an existing patient, and what would the following package cost?
The Fifty 410 alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
06. Mochi Health
The comparison point for Mochi Health: Membership and dose-based medication charges must be added together.
Mochi Health organizes care around a recurring membership, with medication purchased separately. Its public explanation of dose-based pricing matters when evaluating older reviews that describe one flat medication charge. A current account quote can differ from those earlier summaries.
The ongoing membership is advertised at $79, with a $39 first-month offer for eligible newcomers. The August 2026 medication explanation lists semaglutide between $60 and $99 and tirzepatide between $90 and $199. Combining the ongoing membership with those ranges gives illustrative totals of $139–$178 and $169–$278, before any additional applicable item.
A question to put to the provider: What will my membership and medication cost together at my prescribed tier, and when is each payment collected?
Read the Mochi Health provider file and cost explanation for the connected details.
Your starting point: WeightCare
WeightCare describes telehealth assessment, prescribed medication, clinician messaging, and check-ins. Its page includes several commitment lengths and inconsistent statements about some eligibility and location details.
The semaglutide monthly option is $399, while a three-month package is $747 paid at the beginning. Lower six- and twelve-month equivalents require their own full commitment calculations. Confirm starter eligibility and the patient’s state directly.
What remains owed under the package or financing agreement if the clinician changes or stops treatment?
Make the decision concrete
Bring these three checks to the shortlist. If an answer describes another product, a different payment period, or a service you are not eligible for, the comparison is not finished.
- Resolve the plan’s starter and state eligibility before accepting a financed package.
- Request the named product, total initial payment, and next renewal in the same written quote.
- Confirm how the receiving clinician reviews existing treatment and how questions are handled between orders.
Separate the product from the provider
FDA approval belongs to a particular drug product, not to a review site’s list or a telehealth brand. A compounded preparation has not received that approval. Ingredient similarity does not establish the same route, formulation, manufacturing controls, or evidence.
Ask the clinician why the exact prescription fits your medical needs. Then ask the pharmacy for the label and instructions appropriate to that product. Read what compounding and FDA approval mean if those terms are being used interchangeably in a promotion.
Before accepting another offer
Keep the current agreement, prescription label, and any pending order information together. A new enrollment does not automatically stop the previous company’s next charge or authorize a continuation prescription.
Use the questions-before-purchase checklist to record the answers in your own words. A useful next step is a clear conversation and a complete proposal, not a decision based on a rank alone.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- CoreAge Rx: official treatment overview ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: current sale offer ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: plan billing explained ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: contact and professional-entity disclosures ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: purchasing process ↗Provider-published information · Checked September 22, 2026
- Brightmeds: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Yucca Health: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- GobyMeds: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Fifty 410: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Online Medical Weight Loss Program | Mochi Health ↗Provider-published information · Checked September 22, 2026
- Mochi: August 2026 dose-based pricing ↗Provider-published information · Checked September 22, 2026
- Contact us | Mochi Health ↗Provider-published information · Checked September 22, 2026
- WeightCare: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026